

Can’t find Liraglutide (Victoza or Saxenda)? Here are the best alternative GLP-1 medications for diabetes and weight loss, with costs and availability info.
If you’ve been trying to fill your Liraglutide prescription without success, you’re not alone. Between manufacturing delays, high demand, and supply chain issues, many patients have been left wondering what their options are.
The good news is that Liraglutide isn’t the only medication in its class. There are several other GLP-1 receptor agonists — and even a newer dual-action option — that may work for you. In this guide, we’ll explain how Liraglutide works and walk you through the most common alternatives your doctor might consider.
Important: Never switch or stop medications without talking to your doctor first. This article is for informational purposes only and is not medical advice.
Liraglutide is a GLP-1 receptor agonist (also called an incretin mimetic). It’s a synthetic version of a hormone your body naturally produces called glucagon-like peptide-1 (GLP-1). This hormone plays a key role in blood sugar regulation and appetite control.
Here’s what Liraglutide does in your body:
Liraglutide is available as:
For more details, read how Liraglutide works: mechanism of action explained.
Semaglutide is the most well-known alternative to Liraglutide and belongs to the same GLP-1 receptor agonist class. It’s made by the same manufacturer, Novo Nordisk.
Key differences from Liraglutide:
Brand names and uses:
Cost: Brand-name Semaglutide costs $900–$1,300 per month without insurance. Rybelsus may be a more accessible option for patients who prefer oral medication over injections.
Dulaglutide is another GLP-1 receptor agonist that’s been available since 2014. It’s made by Eli Lilly and is FDA-approved for type 2 diabetes.
Key differences from Liraglutide:
Cost: Trulicity costs approximately $900–$1,000 per month without insurance. Eli Lilly offers savings cards that can reduce copays for eligible patients.
Note: Dulaglutide is approved for type 2 diabetes but is not FDA-approved for weight loss.
Tirzepatide is a newer medication that works differently from traditional GLP-1 agonists. It’s a dual GIP/GLP-1 receptor agonist, meaning it activates two incretin pathways instead of one. It’s made by Eli Lilly.
Key differences from Liraglutide:
Brand names and uses:
Cost: Approximately $1,000–$1,100 per month without insurance. Eli Lilly offers savings programs through LillyDirect.
Exenatide is one of the oldest GLP-1 receptor agonists, first approved in 2005. While it’s less commonly prescribed today, it remains a viable option, especially when newer medications are unavailable.
Key differences from Liraglutide:
Cost: Byetta costs approximately $700–$900 per month; Bydureon BCise is similar. Because demand is lower, Exenatide may be easier to find in stock.
The best alternative depends on your specific situation:
Talk to your doctor about which medication makes the most sense for your health goals, insurance coverage, and budget. For help finding any of these medications, visit Medfinder.
Before switching to a different medication, it’s worth making sure you’ve exhausted your options for finding Liraglutide. Check out our tips on how to find Liraglutide in stock near you. Generic Liraglutide from Teva and Meitheal is often easier to find than brand-name Victoza.
Not being able to fill your prescription is stressful, but you do have options. Several other medications in the GLP-1 class can provide similar benefits for type 2 diabetes and weight management. The key is working with your doctor to find the right fit — and using tools like Medfinder to locate whichever medication you need.
For more about Liraglutide side effects and what to watch for, read Liraglutide side effects: what to expect and when to call your doctor.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.